Rakovina Therapeutics Inc.
Symbol:
TSXV: RKV
OTCPK: RKVTF
Market Cap:
8M
Purpose
Raise Awareness, Open Market Buying
Sector:
Biotechnology
Summary:
- Founded in 2021 to focus on the development of new DNA-damage (DDR) response-based therapies for the treatment of cancer
- Exclusive access to Deep DockingTM AI Platform to rapidly screen billions of drug candidates against DNA-damage response targets
- Leveraging robust lead-optimization infrastructure already established in collaboration with the University of British Columbia